Hyperbaric oxygenation and antianginal... (1992 study) Skip to main content
Study Anesteziol Reanimatol 1992

Hyperbaric oxygenation and antianginal preparations: the effect of a single combined use on the functional indices of the state of the heart in patients with angina pectoris

Seriakov V, Efuni S, Sidorenko B, Anesteziol Reanimatol, 1992

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers studied how a single hyperbaric oxygen therapy session combined with heart medications affected heart function in 35 patients with angina (chest pain from reduced blood flow to the heart).

What They Found

This was a study of 35 patients with ischemic heart disease and exertional angina (NYHA class II-III) who received a single hyperbaric oxygen session (1.5 ATA, 40 minutes) combined with one of three antianginal drugs: nifedipine (20 mg), propranolol (40 mg), or nitroglycerin (6.5 mg), all given orally. Hyperbaric oxygen reduced the indirect hemodynamic effect of nifedipine. It made propranolol's heart-rate-lowering and contractility-lowering effects stronger. Hyperbaric oxygen had no effect on the hemodynamic action of the nitroglycerin preparation.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a small study of 35 patients examining only a single combined-treatment session, so it does not show what happens with repeated hyperbaric oxygen exposure or long-term drug interactions.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Cardiac
Source Pubmed
PubMed ID 1416216
Year Published 1992
Journal Anesteziol Reanimatol
MeSH Terms Angina Pectoris; Combined Modality Therapy; Hemodynamics; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Nifedipine; Nitroglycerin; Propranolol

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 16, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology